Drug factory · FDA FEI 3013669013
Petnet Solutions, Inc.
660 1st Avenue, Room 140, New York, NY, United States
No problems found at FDA's last inspection, Sep 19, 2025.
No Action Indicated: inspectors found no objectionable conditions.
2 drug inspections on record since 2017: 1 with no problems, 1 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Fluoroestradiol F-18 | Makes it | GE Healthcare Inc. | 72874-001 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Sep 19, 2025 | No problems found | Drug Quality Assurance | — |
| Nov 15, 2017 | Problems found, fixed voluntarily | Drug Quality Assurance | 1 |
What inspectors wrote down
From FDA's Form 483 citations: conditions an investigator observed that may violate drug manufacturing rules, as FDA published them.
Nov 15, 2017 inspection
- Procedures not in writing, fully followed 21 CFR 211.22(d)
The responsibilities and procedures applicable to the quality control unit are not fully followed.
Registered with FDA for: positron emission tomography drug production.